| Nasal discharge (n = 56) | Pharynx (n = 35) | Tonsillar (n = 39) | Sputum (n = 6) | p value |
Gender |
|
|
|
|
|
Male | 37 | 25 | 25 | 3 | 0.75 |
Female | 19 | 10 | 14 | 3 |
|
Age |
|
|
|
|
|
0 - 1 | 6 | 0 | 0 | 0 | 0.03 |
1 - 18 | 50 | 33 | 38 | 1 | <0.01 |
19 - 64 | 0 | 2 | 1 | 2 | <0.01 |
65- | 0 | 0 | 0 | 3 | <0.01 |
Season |
|
|
|
|
|
Spring | 19 | 5 | 14 | 4 | 0.03 |
Summer | 11 | 8 | 11 | 1 | 0.78 |
Fall | 14 | 8 | 6 | 0 | 0.40 |
Winter | 12 | 14 | 8 | 1 | 0.17 |
Antomicrobial susceptibility |
|
|
|
|
|
Minocycline susceptible | 42 | 29 | 34 | 6 | 0.28 |
Minocycline no susceptible | 14 | 6 | 5 | 0 |
|
Clarithromycin susceptible | 13 | 14 | 15 | 3 | 0.16 |
Clarithromycin no susceptible | 43 | 21 | 24 | 3 |
|
Clindamycin susceptible | 38 | 25 | 30 | 5 | 0.72 |
Clindamycin no susceptible | 18 | 10 | 9 | 1 |
|
Ciprofloxacin susceptible | 40 | 23 | 23 | 4 | 0.66 |
Ciprofloxacin no susceptible | 16 | 12 | 16 | 2 |
|